Exact Mass: 618.0374

Exact Mass Matches: 618.0374

Found 40 metabolites which its exact mass value is equals to given mass value 618.0374, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sceptrin

N-[[(1R,2S,3S,4R)-2,3-bis(2-amino-1H-imidazol-5-yl)-4-[[(4-bromo-1H-pyrrole-2-carbonyl)amino]methyl]cyclobutyl]methyl]-4-bromo-1H-pyrrole-2-carboxamide

C22H24Br2N10O2 (618.045)


   

Heptacarboxyporphyrin

21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),4,6,8,10,12,14,16(22),17,19-undecaene-2,4,5,7,9,10,23-heptacarboxylic acid

C27H14N4O14 (618.0507)


   

ADP ribose 1',2'-cyclic phosphate

5-({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}methyl)-6-hydroxy-2-oxo-tetrahydro-2H-2λ⁵-furo[2,3-d][1,3,2]dioxaphosphol-2-olate

C15H19N5O16P3 (618.004)


Adp ribose 1,2-cyclic phosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adp ribose 1,2-cyclic phosphate can be found in a number of food items such as sparkleberry, oval-leaf huckleberry, hedge mustard, and barley, which makes adp ribose 1,2-cyclic phosphate a potential biomarker for the consumption of these food products.

   

Ascoquinone A

Ascoquinone A

C30H18O15 (618.0646)


   

N,N-[[[2-Amino-4-(2-amino-1H-imidazol-5-yl)-4,5,6,7-tetrahydro-1H-benzimidazole]-5,6-diyl]bis(methylene)]bis(4-bromo-1H-pyrrole-2-carboxamide)

N,N-[[[2-Amino-4-(2-amino-1H-imidazol-5-yl)-4,5,6,7-tetrahydro-1H-benzimidazole]-5,6-diyl]bis(methylene)]bis(4-bromo-1H-pyrrole-2-carboxamide)

C22H24Br2N10O2 (618.045)


   
   

5-O-galloyl-3,4-(S)-hexahydroxydiphenoyl proto-quercitol

5-O-galloyl-3,4-(S)-hexahydroxydiphenoyl proto-quercitol

C27H22O17 (618.0857)


   

didebromonagelamide A

didebromonagelamide A

C22H24Br2N10O2 (618.045)


   

Dimethyl perfluoro-1,10-decanedicarboxylate

Dimethyl perfluoro-1,10-decanedicarboxylate

C14H6F20O4 (617.9947)


   

2-(Perfluorodecyl)ethyl acrylate

2-(Perfluorodecyl)ethyl acrylate

C15H7F21O2 (618.0111)


   

Chloro(mesitylene)[(S,S)-N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine]ruthenium(II)

Chloro(mesitylene)[(S,S)-N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine]ruthenium(II)

C30H29ClN2O2RuS (618.0682)


   

2,5-bis-(4-azido-2-sulfobenzylidene)- cyclopentanone, disodium salt, tetrahydrate

2,5-bis-(4-azido-2-sulfobenzylidene)- cyclopentanone, disodium salt, tetrahydrate

C19H20N6Na2O11S2 (618.0427)


   

[mu-[orthoborato(2-)-O:O]]diphenyldimercury

[mu-[orthoborato(2-)-O:O]]diphenyldimercury

C12H11BHg2O3 (618.0214)


   

Ceftazidime dihydrochloride

Ceftazidime dihydrochloride

C22H24Cl2N6O7S2 (618.0525)


   

[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] (6-hydroxy-2-oxido-2-oxo-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3,2]dioxaphosphol-5-yl)methyl phosphate

[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] (6-hydroxy-2-oxido-2-oxo-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3,2]dioxaphosphol-5-yl)methyl phosphate

C15H19N5O16P3-3 (618.004)


   

UDP-N-acetyl-alpha-D-mannosaminouronate(3-)

UDP-N-acetyl-alpha-D-mannosaminouronate(3-)

C17H22N3O18P2-3 (618.0374)


   

UDP-2-acetamido-2-deoxy-alpha-D-glucuronate(3-)

UDP-2-acetamido-2-deoxy-alpha-D-glucuronate(3-)

C17H22N3O18P2-3 (618.0374)


   

(2S,3S,4R,5R,6R)-5-(acetylamino)-4-ammonio-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}phosphinato)oxy]phosphinato}oxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate

(2S,3S,4R,5R,6R)-5-(acetylamino)-4-ammonio-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}phosphinato)oxy]phosphinato}oxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate

C17H24N4O17P2-2 (618.0612)


   

(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-1-oxidoethylidene]amino]-3-[[2-(2-hydroxyethyl)-3-iminopyrazol-1-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;sulfuric acid

(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-1-oxidoethylidene]amino]-3-[[2-(2-hydroxyethyl)-3-iminopyrazol-1-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;sulfuric acid

C19H22N8O10S3-2 (618.0621)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

2-phospho-cyclic ADP-ribose

2-phospho-cyclic ADP-ribose

C15H19N5O16P3-3 (618.004)


   

ADP ribose 1,2-cyclic phosphate

ADP ribose 1,2-cyclic phosphate

C15H19N5O16P3-3 (618.004)


   
   

UDP-N-acetyl-D-mannosaminouronate(3-)

UDP-N-acetyl-D-mannosaminouronate(3-)

C17H22N3O18P2-3 (618.0374)


   

Heptacarboxyporphyrin

Heptacarboxyporphyrin

C27H14N4O14 (618.0507)


   

ADP-D-ribose 1,2-cyclic phosphate(3-)

ADP-D-ribose 1,2-cyclic phosphate(3-)

C15H19N5O16P3-3 (618.004)


   

2-[(5E)-4-oxo-5-[[1-phenyl-3-(4-piperidin-1-ylsulfonylphenyl)pyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid

2-[(5E)-4-oxo-5-[[1-phenyl-3-(4-piperidin-1-ylsulfonylphenyl)pyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid

C26H26N4O6S4 (618.0735)


   

UDP-2-acetamido-2-deoxy-D-glucuronate(3-)

UDP-2-acetamido-2-deoxy-D-glucuronate(3-)

C17H22N3O18P2-3 (618.0374)


   

UDP-N-acetyl-beta-D-mannosaminouronate(3-)

UDP-N-acetyl-beta-D-mannosaminouronate(3-)

C17H22N3O18P2-3 (618.0374)


   

N-[[(1R,2S,3S,4R)-2,3-bis(2-amino-1H-imidazol-5-yl)-4-[[(4-bromo-1H-pyrrole-2-carbonyl)amino]methyl]cyclobutyl]methyl]-4-bromo-1H-pyrrole-2-carboxamide

N-[[(1R,2S,3S,4R)-2,3-bis(2-amino-1H-imidazol-5-yl)-4-[[(4-bromo-1H-pyrrole-2-carbonyl)amino]methyl]cyclobutyl]methyl]-4-bromo-1H-pyrrole-2-carboxamide

C22H24Br2N10O2 (618.045)


   

2-phospho-cyclic ADP-ribose(3-)

2-phospho-cyclic ADP-ribose(3-)

C15H19N5O16P3 (618.004)


A nucleotide-sugar oxoanion obtained by deprotonation of the diphosphate OH groups of 2-phospho-cyclic ADP-ribose.

   

4-bromo-n-[(2-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-3,4-bis(2-imino-1,3-dihydroimidazol-4-yl)cyclobutyl)methyl]-1h-pyrrole-2-carboxamide

4-bromo-n-[(2-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-3,4-bis(2-imino-1,3-dihydroimidazol-4-yl)cyclobutyl)methyl]-1h-pyrrole-2-carboxamide

C22H24Br2N10O2 (618.045)


   

4-bromo-n-[(6-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-2-imino-7-(2-imino-1,3-dihydroimidazol-4-yl)-1,3,4,5,6,7-hexahydro-1,3-benzodiazol-5-yl)methyl]-1h-pyrrole-2-carboxamide

4-bromo-n-[(6-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-2-imino-7-(2-imino-1,3-dihydroimidazol-4-yl)-1,3,4,5,6,7-hexahydro-1,3-benzodiazol-5-yl)methyl]-1h-pyrrole-2-carboxamide

C22H24Br2N10O2 (618.045)


   

2-{3-[2,3-dihydroxy-5-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]-4,5-dihydroxyphenyl}-3,5,7-trihydroxychromen-4-one

2-{3-[2,3-dihydroxy-5-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]-4,5-dihydroxyphenyl}-3,5,7-trihydroxychromen-4-one

C30H18O15 (618.0646)


   

4-bromo-n-{[(2r,4s)-2-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-3,4-bis(2-imino-1,3-dihydroimidazol-4-yl)cyclobutyl]methyl}-1h-pyrrole-2-carboxamide

4-bromo-n-{[(2r,4s)-2-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-3,4-bis(2-imino-1,3-dihydroimidazol-4-yl)cyclobutyl]methyl}-1h-pyrrole-2-carboxamide

C22H24Br2N10O2 (618.045)


   

4-bromo-n-{[(5s,6r,7s)-6-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-2-imino-7-(2-imino-1,3-dihydroimidazol-4-yl)-1,3,4,5,6,7-hexahydro-1,3-benzodiazol-5-yl]methyl}-1h-pyrrole-2-carboxamide

4-bromo-n-{[(5s,6r,7s)-6-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-2-imino-7-(2-imino-1,3-dihydroimidazol-4-yl)-1,3,4,5,6,7-hexahydro-1,3-benzodiazol-5-yl]methyl}-1h-pyrrole-2-carboxamide

C22H24Br2N10O2 (618.045)


   

3,4,5,13,14,20,21,22-octahydroxy-8,17-dioxo-9,16-dioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaen-11-yl 3,4,5-trihydroxybenzoate

3,4,5,13,14,20,21,22-octahydroxy-8,17-dioxo-9,16-dioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaen-11-yl 3,4,5-trihydroxybenzoate

C27H22O17 (618.0857)


   

4-bromo-n-{[(5s,6s,7r)-6-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-2-imino-7-(2-imino-1,3-dihydroimidazol-4-yl)-1,3,4,5,6,7-hexahydro-1,3-benzodiazol-5-yl]methyl}-1h-pyrrole-2-carboxamide

4-bromo-n-{[(5s,6s,7r)-6-{[(4-bromo-1h-pyrrol-2-yl)formamido]methyl}-2-imino-7-(2-imino-1,3-dihydroimidazol-4-yl)-1,3,4,5,6,7-hexahydro-1,3-benzodiazol-5-yl]methyl}-1h-pyrrole-2-carboxamide

C22H24Br2N10O2 (618.045)


   
   

1,2,5,6,8-pentahydroxy-3-{[(3,4,5,7,8-pentahydroxy-9,10-dioxoanthracen-2-yl)methoxy]methyl}anthracene-9,10-dione

1,2,5,6,8-pentahydroxy-3-{[(3,4,5,7,8-pentahydroxy-9,10-dioxoanthracen-2-yl)methoxy]methyl}anthracene-9,10-dione

C30H18O15 (618.0646)


   

(10s,11r,13r,14s,15s)-3,4,5,13,14,20,21,22-octahydroxy-8,17-dioxo-9,16-dioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaen-11-yl 3,4,5-trihydroxybenzoate

(10s,11r,13r,14s,15s)-3,4,5,13,14,20,21,22-octahydroxy-8,17-dioxo-9,16-dioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaen-11-yl 3,4,5-trihydroxybenzoate

C27H22O17 (618.0857)